 Glomerular Filtration Rate
"Glomerular Filtration Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance.
| Descriptor ID |
D005919
|
| MeSH Number(s) |
E01.370.390.400.300 G08.852.357
|
| Concept/Terms |
Glomerular Filtration Rate- Glomerular Filtration Rate
- Filtration Rate, Glomerular
- Filtration Rates, Glomerular
- Glomerular Filtration Rates
- Rate, Glomerular Filtration
- Rates, Glomerular Filtration
|
Below are MeSH descriptors whose meaning is more general than "Glomerular Filtration Rate".
Below are MeSH descriptors whose meaning is more specific than "Glomerular Filtration Rate".
This graph shows the total number of publications written about "Glomerular Filtration Rate" by people in this website by year, and whether "Glomerular Filtration Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 1 | 2 | | 1998 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 2 | 3 | 5 | | 2003 | 0 | 4 | 4 | | 2004 | 1 | 3 | 4 | | 2005 | 1 | 5 | 6 | | 2006 | 1 | 3 | 4 | | 2007 | 2 | 11 | 13 | | 2008 | 5 | 16 | 21 | | 2009 | 6 | 11 | 17 | | 2010 | 6 | 14 | 20 | | 2011 | 5 | 14 | 19 | | 2012 | 4 | 11 | 15 | | 2013 | 7 | 14 | 21 | | 2014 | 10 | 18 | 28 | | 2015 | 5 | 14 | 19 | | 2016 | 6 | 16 | 22 | | 2017 | 7 | 22 | 29 | | 2018 | 7 | 21 | 28 | | 2019 | 9 | 21 | 30 | | 2020 | 5 | 24 | 29 | | 2021 | 6 | 23 | 29 | | 2022 | 0 | 21 | 21 | | 2023 | 0 | 20 | 20 | | 2024 | 12 | 12 | 24 | | 2025 | 3 | 11 | 14 |
To return to the timeline, click here.
Below are the most recent publications written about "Glomerular Filtration Rate" by people in Profiles.
-
Cherney DZI, Belmar N, Bjornstad P, Chacko MM, Gunnarsson TP, Hodgin JB, Kretzler M, Pruijm M, Schytz PA, Tuttle KR. Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2025 Oct 30; 40(11):2182-2192.
-
Perez L, Struemph T, Raghavan S, You Z, Schwartz GG, Nowak KL, Chonchol M, Jovanovich A. Diet quality, unprocessed plant-based foods, and vascular function in adults with CKD: Secondary analysis of a pilot randomized clinical trial. Clin Nephrol. 2025 Oct; 104(4):273-284.
-
Darvish S, Coppock ME, Murray KO, Craighead DH, Chonchol M, Nowak KL, Seals DR, Rossman MJ. Sex-specific effects of mild kidney dysfunction on vascular function in midlife and older adults. Am J Physiol Heart Circ Physiol. 2025 Aug 01; 329(2):H401-H408.
-
Petr V, Tichanek F, Liu SL, Poppelaars F, Renner B, Laskowski J, Purohit S, Zhao M, Jalal D, Heeger PS, Thurman JM. Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction. Am J Transplant. 2025 Oct; 25(10):2173-2181.
-
Mahmud FH, Bjornstad P, Clarson C, Clarke A, Anthony SJ, Curtis J, Elia YT, McArthur L, Mertens L, Moineddin R, Kirsch S, Coles N, Maione M, Furman M, Babalola F, Tommerdahl KL, Harrington J, Riddell MC, Prasad P, Huang L, Heerspink HJL, Cherney DZI. Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial. Nat Med. 2025 Jul; 31(7):2317-2324.
-
van Baar MJB, Muskiet MHA, Scholtes RA, Touw DJ, Nieuwdorp M, Kramer MHH, Joles JA, Cherney DZI, Bjornstad P, Krebber MM, van Raalte DH. Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial. Diabetes Obes Metab. 2025 Jul; 27(7):3943-3956.
-
Wang X, Hasler J, Miron B, Wang M, Afghahi A, Royce TJ, Geynisman DM. Impact of Renal Function Eligibility Criteria on Clinical Trials and Real-World Survival Outcomes Among Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2025 Aug; 23(4):102362.
-
Fstkchian AK, Lowe RN, Saseen JJ. Statin therapy prescribing in atherosclerotic cardiovascular disease patients with chronic kidney disease. J Am Pharm Assoc (2003). 2025 Jul-Aug; 65(4):102395.
-
van Eeghen SA, Pyle L, Narongkiatikhun P, Choi YJ, Obeid W, Parikh CR, Vosters TG, van Valkengoed IG, Krebber MM, Touw DJ, den Heijer M, Bjornstad P, van Raalte DH, Nokoff NJ. Unveiling mechanisms underlying kidney function changes during sex hormone therapy. J Clin Invest. 2025 May 01; 135(9).
-
Kwok R, Kishore K, Zafari T, Koye DN, Hachem M, de Boer IH, Jeong TD, Min WK, Porrini E, Bjornstad P, MacIsaac RJ, Churilov L, Ekinci EI. Comparative performance of CKD-EPI equations in people with diabetes: An international pooled analysis of individual participant data. Diabetes Res Clin Pract. 2025 May; 223:112104.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|